Fundraising Fox

Totus Medicines

27 employees on LinkedIn · 2 known investors

Totus Medicines is a biopharmaceutical company developing small molecule drugs to address untreatable diseases by combining approaches in molecular design, structural biology, genetics, and cell biology. The company focuses on oncology and other therapeutic areas for patients with currently incurable conditions.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

Founders & leadership

ND
Neil Dhawan, PhDCo-Founder
NU
Nassim Usman, PhDCEO and President

Investors · 2

DCVC (Data Collective)Palo Alto · $5M – $25M
Social Impact CapitalreportedNew York · $100K – $1.5M

In the news

Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officerglobenewswire.com · Jan 2025Totus Medicines: $66 Million Raised To Transform Small Molecule Drug Discovery And Developmentpulse2.com · Dec 2023Totus Medicines Closes $66M Series B Fundingfinsmes.com · Dec 2023This Biotech Company Raised $40 Million To Develop Treatments For ‘Undruggable’ Diseasesforbes.com · Dec 2021Totus tots up $40M in series A funding to go after competitive cancer space | Fierce Biotechfiercebiotech.com · Dec 2021

Frequently asked questions

What does Totus Medicines do?
Totus Medicines is a biopharmaceutical company developing small molecule drugs to address untreatable diseases by combining approaches in molecular design, structural biology, genetics, and cell biology. The company focuses on oncology and other therapeutic areas for patients with currently incurable conditions.
Who founded Totus Medicines?
Totus Medicines was founded by Neil Dhawan, PhD.
Who are Totus Medicines's investors?
Totus Medicines's investors include DCVC (Data Collective), Social Impact Capital.